Photodynamic therapy (
PDT) has been explored as a therapeutic strategy to clear toxic
amyloid aggregates involved in
neurodegenerative disorders such as
Alzheimer's disease. A major limitation of
PDT is off-target oxidation, which can be lethal for the surrounding cells. We have shown that a novel class of oligo-p-phenylene ethynylenes (OPEs) exhibit selective binding and fluorescence turn-on in the presence of prefibrillar and fibrillar aggregates of disease-relevant
proteins such as
amyloid-β (Aβ) and α-
synuclein. Concomitant with fluorescence turn-on, OPE also photosensitizes
singlet oxygen under illumination through the generation of a triplet state, pointing to the potential application of OPEs as
photosensitizers in
PDT. Herein, we investigated the photosensitizing activity of an anionic OPE for the photo-oxidation of Aβ fibrils and compared its efficacy to the well-known but nonselective
photosensitizer methylene blue (MB). Our results show that, while MB photo-oxidized both monomeric and fibrillar conformers of Aβ40, OPE oxidized only Aβ40 fibrils, targeting two
histidine residues on the fibril surface and a
methionine residue located in the fibril core. Oxidized fibrils were shorter and more dispersed but retained the characteristic β-sheet rich fibrillar structure and the ability to seed further fibril growth. Importantly, the oxidized fibrils displayed low toxicity. We have thus discovered a class of novel
theranostics for the simultaneous detection and oxidization of
amyloid aggregates. Importantly, the selectivity of OPE's photosensitizing activity overcomes the limitation of off-target oxidation of traditional
photosensitizers and represents an advancement of
PDT as a viable strategy to treat
neurodegenerative disorders.